The Latest Breaking News from OptumRX

EXCLUSIVE: Shanon and Bill Schmidtknecht tell Rhian Lubin of their grief for son Cole and their fight for a fairer health insurance system

A Wisconsin couple is suing Walgreens and a pharmacy benefits company alleging their son died because he couldn't afford a sudden $500 jump in the cost of his asthma medication

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.16%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.04%. US stock indexes today are mixed. Reduced geopolitical tensions are positive for stocks...

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.42%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.32%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.57%. US stock indexes are moderately higher today as geopolitical tensions ease from the...

Pharmaceutical giant Eli Lilly is slashing the list prices for some of its most popular insulin products by 70 percent.

Pharmaceutical giant Eli Lilly is slashing the list prices for some of its most popular insulin products by 70% and capping insulin copays at US$35 for uninsured patients and those with private health insurance. These changes follow efforts by the federal government, the California state government, nonprofits and some companies…

WASHINGTON — Factions of the health care system and members of Congress are turning their fire on an oft-maligned part of the drug pricing system — the middlemen who negotiate discounts with drug companies on behalf of health plans.

PBMs argue that the rebates they collect from drug companies in exchange for coverage by a health plan are used to lower premiums.

California's Attorney General Rob Bonta sued the six major companies that dominate the U.S. insulin market